Obalon Announces First Quarter 2017 Financial Results
10. Mai 2017 08:01 ET
|
Obalon Therapeutics, Inc.
SAN DIEGO, May 10, 2017 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...
Obalon Announces First Quarter 2017 Financial Results Conference Call
05. Mai 2017 09:02 ET
|
Obalon Therapeutics, Inc.
SAN DIEGO, May 05, 2017 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...
Obalon Balloon System to be Included in Two Presentations at the Aesthetic Meeting 2017
28. April 2017 17:31 ET
|
Obalon Therapeutics, Inc.
SAN DIEGO, April 28, 2017 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...
David Moatazedi Joins Obalon Therapeutics, Inc. Board of Directors
15. März 2017 16:31 ET
|
Obalon Therapeutics, Inc.
SAN DIEGO, March 15, 2017 (GLOBE NEWSWIRE) -- Obalon Therapeutics Inc. (NASDAQ:OBLN), a vertically integrated medical technology company, announced today that David Moatazedi, Senior Vice...
Obalon Therapeutics, Inc. Announces Fourth Quarter and Full Year 2016 Financial Results
23. Februar 2017 07:45 ET
|
Obalon Therapeutics, Inc.
SAN DIEGO, Feb. 23, 2017 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...
Obalon Therapeutics, Inc. Announces Fourth Quarter and Year End 2016 Financial Results Conference Call
15. Februar 2017 08:43 ET
|
Obalon Therapeutics, Inc.
SAN DIEGO, Feb. 15, 2017 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...
Obalon Therapeutics, Inc. to Ring The Nasdaq Stock Market Closing Bell
19. Januar 2017 08:18 ET
|
Obalon Therapeutics, Inc.
SAN DIEGO, Jan. 19, 2017 (GLOBE NEWSWIRE) -- Obalon Therapeutics Inc. (NASDAQ:OBLN), a vertically integrated medical technology company, announced today that they will be ringing the Nasdaq Stock...
Jonah Shacknai Joins Obalon Therapeutics, Inc. Board of Directors
17. Januar 2017 08:27 ET
|
Obalon Therapeutics, Inc.
SAN DIEGO, Jan. 17, 2017 (GLOBE NEWSWIRE) -- Obalon Therapeutics Inc. (NASDAQ:OBLN), a vertically integrated medical technology company, announced today that Jonah Shacknai, Executive Chairman of...
Obalon Announces Initial Commercial Patient Placements of the First and Only Swallowable, FDA-Approved Balloon System for Weight Loss
13. Januar 2017 08:02 ET
|
Obalon Therapeutics, Inc.
SAN DIEGO, Calif., Jan. 13, 2017 (GLOBE NEWSWIRE) -- Obalon Therapeutics Inc. (NASDAQ:OBLN), a vertically integrated medical technology company, announced that it has begun U.S. commercial shipments...
Obalon Therapeutics To Present at Two Upcoming Investor Conferences
14. November 2016 07:24 ET
|
Obalon Therapeutics, Inc.
SAN DIEGO, Nov. 14, 2016 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable,...